Glycoconjugates: synthesis, functional studies, and therapeutic developments

SS Shivatare, VS Shivatare, CH Wong - Chemical reviews, 2022 - ACS Publications
Glycoconjugates are major constituents of mammalian cells that are formed via covalent
conjugation of carbohydrates to other biomolecules like proteins and lipids and often …

Targeting galectin-driven regulatory circuits in cancer and fibrosis

KV Mariño, AJ Cagnoni, DO Croci… - Nature Reviews Drug …, 2023 - nature.com
Galectins are a family of endogenous glycan-binding proteins that have crucial roles in a
broad range of physiological and pathological processes. As a group, these proteins use …

Exploiting innate immunity for cancer immunotherapy

M Yi, T Li, M Niu, Q Mei, B Zhao, Q Chu, Z Dai, K Wu - Molecular cancer, 2023 - Springer
Immunotherapies have revolutionized the treatment paradigms of various types of cancers.
However, most of these immunomodulatory strategies focus on harnessing adaptive …

Glycomimetics for the inhibition and modulation of lectins

S Leusmann, P Ménová, E Shanin, A Titz… - Chemical Society …, 2023 - pubs.rsc.org
Carbohydrates are essential mediators of many processes in health and disease. They
regulate self-/non-self-discrimination, are key elements of cellular communication, cancer …

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers

Q Tang, Y Chen, X Li, S Long, Y Shi, Y Yu… - Frontiers in …, 2022 - frontiersin.org
Programmed cell death protein-1 (PD-1) is a checkpoint receptor expressed on the surface
of various immune cells. PD-L1, the natural receptor for PD-1, is mainly expressed in tumor …

Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association

CC Wu, YA Wang, JA Livingston, J Zhang… - Nature …, 2022 - nature.com
Owing to a lack of response to the anti-PD1 therapy for most cancer patients, we develop a
network approach to infer genes, pathways, and potential therapeutic combinations that are …

Strategies targeting tumor immune and stromal microenvironment and their clinical relevance

M Hu, L Huang - Advanced Drug Delivery Reviews, 2022 - Elsevier
The critical role of tumor microenvironment (TME) in tumor initiation and development has
been well-recognized after more than a century of studies. Numerous therapeutic …

Galectin-1: a traditionally immunosuppressive protein displays context-dependent capacities

X Yu, J Qian, L Ding, S Yin, L Zhou… - International Journal of …, 2023 - mdpi.com
Galectin–Carbohydrate interactions are indispensable to pathogen recognition and immune
response. Galectin-1, a ubiquitously expressed 14-kDa protein with an evolutionarily …

Placental galectins in cancer: why we should pay more attention

C Fuselier, A Dumoulin, A Paré, R Nehmé, S Ajarrag… - Cells, 2023 - mdpi.com
The first studies suggesting that abnormal expression of galectins is associated with cancer
were published more than 30 years ago. Today, the role of galectins in cancer is relatively …

[HTML][HTML] Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations

X Chen, LJ Chen, XF Peng, L Deng, Y Wang, JJ Li… - Translational …, 2024 - Elsevier
Colorectal cancer (CRC) is the third most prevalent cancer in the world. The PD-1/PD-L1
pathway plays a crucial role in modulating immune response to cancer, and PD-L1 …